Xlife Sciences AG (SWX: XLS)
Switzerland
· Delayed Price · Currency is CHF 25.00
-0.40 (-1.57%)
Jan 3, 2025, 9:00 AM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 143.54 million as of January 3, 2025. Its market cap has decreased by -30.60% in one year.
Market Cap
143.54M
Enterprise Value
293.05M
Revenue
990.27K
Ranking
n/a
PE Ratio
9.58
Stock Price
25.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 143.54M, a decrease of -40.30%. That is a compound annual growth rate of -16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 143.54M | -1.57% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 206.14B |
| Novartis AG | 177.98B |
| Lonza Group AG | 38.57B |
| Alcon | 37.78B |
| Galderma Group AG | 24.23B |
| Straumann Holding AG | 18.00B |
| Sonova Holding AG | 17.66B |
| Sandoz Group AG | 16.47B |